In finance, not making mistakes is not at all critical, and mistakes happpens all the time. Regulatory compliance is critical, as it provides a thorough legal defense even in case of failure.

The lack of efficiency in finance (or pharma for that matter) is not driven by a wish for quality, but purely from a fear of stepping outside regulatory compliance with no individual wanting to be responsible for any process optimization that could later be seen as non-compliant.

Younger companies on the other hand might realize that compliance controls are, in fact, something the company defines themselves and can structure and optimize however they'd like, allowing for both high throughput and compliance. It's just hard to implement in older companies where half the staff would fight back as their role exists purely due to poor processes and their overhead.